Sign in
4

Changes in Ownership

Aptevo Therapeutics Inc. Filed Acc 0000950170-24-009003

EVP, COO acquired 1,833 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Lamothe Jeffrey G. EVP, COO 2024-01-28 Option exercise +1,833 28,337 D
Derivatives
Lamothe Jeffrey G. EVP, COO 2024-01-28 Option exercise · Restricted Stock Unit −1,833 0 D
Loading xslF345X05/ownership.xml…